Posttraumatic Stress Disorder in Parents and Children After Discharge From the Pediatric Intensive Care Unit (PTSD)

December 23, 2021 updated by: Ayşegül Karaca, Eskisehir Osmangazi University

Background: If disorders that occur immediately after a trauma are not treated, they may become chronic and turn into severe health problems.

Objectives: This study was conducted with children who had spent time in an intensive care unit and their parents to examine the development of posttraumatic stress disorder (PTSD) in both children and parents.

Methods: The study was a cross-sectional study. A total of 110 children, 98 mothers and 80 fathers were included in the study.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Background: If disorders that occur immediately after a trauma are not treated, they may become chronic and turn into severe health problems.

Objectives: This study was conducted with children who had spent time in an intensive care unit and their parents to examine the development of posttraumatic stress disorder (PTSD) in both children and parents.

Methods: The research was carried out in the intensive care unit of a children's hospital in Turkey. Children between the ages of 8-12 who had spent time in the PICU over the period January 1 - March 1, 2019, who had been discharged from the PICU or transferred into another unit during this time, and who met the research criteria were included in the study. Between these dates, the total number of children discharged from intensive care or transferred into another unit was 166. Of these children, 138 were between the ages of 8-12. During this period, three children who died, two children whose general condition meant they were unable to participate in the study, and 23 children for whom parental consent could not be obtained were excluded from the study. The study was ultimately completed with 110 children. In addition, the parents of the children in the sample group (98 mothers and 80 fathers) who were alive, reachable, and who agreed to participate were included in the study.

Results: A total of 110 children, 98 mothers and 80 fathers who agreed to participate in the study, met the sample selection criteria, and were available throughout were included in the study.

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Mamak
      • Ankara, Mamak, Turkey, 06100
        • Aysegul

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

In the power analysis conducted using the G*power 3.0.10 program and an alpha=0.05 margin of error, the power of the study was 85% for 110 children, 93.3% for the 98 mothers and 81.5% for the 80 fathers.

Description

Inclusion Criteria:

  • The child was between 8-12 years old,
  • The child had an accompanying adult present,
  • The child was conscious and/or able to communicate verbally,
  • The child did not have any intellectual disability,
  • There were no challenges in communicating with the family and/or the child (i.e., they spoke Turkish, were able to communicate),
  • The child's stay at the PICU was no longer than 29 days,
  • The child and their family volunteered to participate in the study.

Exclusion Criteria:

  • All participants who do not meet the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
application of the post-traumatic stress disorder scale
Time Frame: on day 0-3 of discharge
post traumatic stress disorder scale applied to children
on day 0-3 of discharge
application of the post-traumatic stress disorder scale
Time Frame: on day 0-3 of discharge
post traumatic stress disorder scale applied to parents
on day 0-3 of discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
application of the post-traumatic stress disorder scale
Time Frame: on day 30-40 of discharge
post traumatic stress disorder scale applied to children
on day 30-40 of discharge

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
application of the post-traumatic stress disorder scale
Time Frame: on day 30-40 of discharge
post traumatic stress disorder scale applied to parents
on day 30-40 of discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ayşegül karaca, aysegulkaraca_88@hotmail.com

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

March 1, 2019

Study Completion (Actual)

January 20, 2020

Study Registration Dates

First Submitted

October 15, 2021

First Submitted That Met QC Criteria

December 23, 2021

First Posted (Actual)

January 11, 2022

Study Record Updates

Last Update Posted (Actual)

January 11, 2022

Last Update Submitted That Met QC Criteria

December 23, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Study1
  • Ayfer Açıkgöz (Other Identifier: Eskisehir OU)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Cannot be shared because it is in the publishing phase.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parents

Clinical Trials on survey application

Subscribe